-
Health Minister urged people with co-morbid conditions like hypertension, sugar, heart ailments and cancer to be very careful and take precautions from SARS-CoV-2.
-
The findings, published in the journal Current Biology, indicates that efforts to promote healthy sleep duration ahead of an immunisation could be an easy way to improve vaccine effectiveness.
-
The team led by researchers at AIIMS Patna noted that COVID-19 can lead to multiorgan damage through the angiotensin-converting enzyme-2 receptor (ACE2), abundant in testicular tissue.
-
An international team of researchers has identified a pan-variant and ultra-potent neutralising antibody that can offset Omicron variants.
-
New York: Rather than evolving from regular transmission among millions of humans, the coronavirus variants of concern from chronic, long Covid patients can be more deadly and need urgent attention, scientists have warned. Earlier studies have shown that some immune-compromised people, such as those taking medication for other chronic disorders, have carried active Covid infections […]
-
Hyderabad: In general, an antibody test (serological test) for Covid-19 is performed in specialized labs, and to get results it takes anywhere from 24 hours to several days. But a new paper test developed by researchers from the Massachusetts Institute of Technology (MIT) has shown that it takes only 10 minutes to find the level of neutralizing antibodies […]
-
Hyderabad: For a long time we have been told about the overall health benefits of having a cup or two of black tea. It now turns out that the black tea not only has impact on holistic health but also can limit the ability of SARS-CoV-2 virus to replicate. A ground breaking collaborative study by […]
-
New Delhi: A cancer patient in US’ Connecticut has become the second longest-known in the world to be infected with Covid as he suffered the infection 471 days, according to a pre-print study, not peer-reviewed. An immunocompromised person in the UK is known to have been the world’s longest-known Covid sufferer — at 505 days. […]
-
California: Researchers have measured the stability and infectivity of four variants of SARS-CoV-2 in 5-10 um-wide aerosolized droplets over a period of 5 seconds to 20 minutes and found a reduction in infectivity by around 90% after 20 minutes; loss of infectivity was associated with relative humidity and aerosol pH, providing insight into the mechanisms […]
-
Washington: A commercial COVID test can quickly determine if you are infected with SARS-CoV-2. However, if a positive result is obtained, there is no equivalent home test to assess how long you have been protected from reinfection. In the Journal of the American Chemical Society (ACS), researchers are now reporting simple and accurate glucose meter-based […]
-
Bangkok: A 32-year-old previously healthy female veterinarian contracted Covid after being exposed to an infected cat, according to the first documented case of suspected cat-to-human transmission. Researchers from the Prince of Songkla University in Thailand reported the case of the vet who was diagnosed with Covid after being sneezed on by a cat owned by […]
-
Bengaluru: The researchers at the Indian Institute of Science (IISc) have developed an alternative mechanism to render viruses like SARS-CoV-2 inactive, the official statement by IISc stated on Monday. In a study published in Nature Chemical Biology, the researchers report the design of a new class of artificial peptides or mini proteins that can not […]
-
New Delhi: The Indian Council of Medical Research (ICMR) on Monday issued guidelines for the management of type 1 diabetes in India. This is the first time that the research body has released guidelines for type 1 diabetes. Earlier, guidelines were released for type 2 diabetes. Balram Bhargava, Department of Health Research Secretary and ICMR […]
-
Hyderabad: The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) on Friday has announced the development of country’s first potential mRNA vaccine candidate to fight SARS-CoV-2. The indigenously developed mRNA vaccine candidate is undergoing pre-clinical studies to evaluate its efficacy to protect against live virus infection, CCMB researchers on Friday said. The mRNA vaccine candidate […]
-
New York: The SARS-CoV-2 virus can directly infect a specialised type of kidney cell, explaining why acute kidney injury is one of the main complications observed in patients with severe Covid-19, finds a study. Primarily known to infect cells in the respiratory tract, physicians were surprised to see that many patients, especially those with severe […]
-
New Delhi: While many people who recover from Covid-19 experience long-term symptoms, such as brain fog or heart problems, increasing evidence suggests that the virus can also impair fertility in men. The pilot study, led by a team of researchers at Jaslok Hospital and the Indian Institute of Technology (IIT) Bombay, suggests that even mild […]
-
Hyderabad: A rural innovator, Narishma Chary Mandaji has developed a medical device that uses first of its kind Centre for Cellular and Molecular Biology (CCMB) approved virus attenuation technology to disable all kind of virus including SARS-CoV-2 up to 99.9 per cent efficacy in an enclosed space, in air, and on the surfaces. Marketed by […]
-
Geneva: The World Health Organisation (WHO) has issued a warning against a new mutant ‘XE’ variant of Omicron, that may be more transmissible than any strain of Covid-19 seen before. This new variant is a recombinant strain, meaning it is a mutant hybrid of the two previous versions of the Omicron variant, BA.1 and BA.2, […]
-
Hyderabad: The Delta variant of SARS-CoV-2, which triggered the intense second Covid wave and caused large number of fatalities, had gained the ability to silently replicate in the epithelial cells, which line the surface of the human body, and learned how to last for a longer duration in the host, a recent study by geneticists […]
-
According to scientists from the Wuhan University in China, NeoCov can penetrate human cells in the same way as SARS-CoV-2.